1.56

1.50% -0.02

Pulmatrix Inc (PULM)

Overview News Price History Financials Discussions Forecast Stock Split

Pulmatrix Inc stock is traded at $1.56, with a volume of 11,443. It is down -1.50% in the last 24 hours and down -10.24% over the past month. Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Previous Close:

$1.54

Open:

$1.5

24h Volume:

11,443

Relative Volume:

0.26

Market Cap:

$5.70M

Revenue:

$3,000

Net Income/Loss:

$-4.53M

P/E Ratio:

-1.2589

EPS:

-1.2392

Net Cash Flow:

$-4.69M

1W Performance:

-3.38%

1M Performance:

-10.24%

6M Performance:

-37.32%

1Y Performance:

-67.79%

1-Day Range:

$1.50

$1.62

1-Week Range:

$1.45

$1.62

52-Week Range:

$1.16

$5.498

Pulmatrix Inc Stock (PULM) Company Profile

Name

Pulmatrix Inc

Sector

Healthcare (1089)

Industry

Biotechnology (604)

Phone

(888) 355-4440

Address

945 CONCORD STREET, FRAMINGHAM, MA

Employee

Twitter

@pulmatrix_inc

Next Earnings Date

2026-08-19

Latest SEC Filings

PULM's Discussions on Twitter

Compare PULM vs VRTX, REGN, ARGX, RVMD, ONC

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PULM Pulmatrix Inc	1.56	5.62M	3,000	-4.53M	-4.69M	-1.2392
VRTX Vertex Pharmaceuticals Inc	515.76	128.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	806.53	82.72B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	990.93	53.26B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	212.00	43.66B	742.00K	-1.37B	-1.07B	-7.0731
ONC Beone Medicines Ltd Adr	362.63	39.31B	5.76B	514.49M	1.10B	4.4813

Pulmatrix Inc Stock (PULM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-18	Initiated	H.C. Wainwright	Buy

Pulmatrix Inc Stock (PULM) Latest News

Aug 16, 2026

Precision Trading with Pulmatrix Inc. (PULM) Risk Zones - Stock Traders Daily

Aug 16, 2026

Aug 14, 2026

Pulmatrix Inc (NASDAQ: PULM) Share Price, PULM Stock News, PULM Share Price & Updates - Kalkine

Aug 14, 2026

Aug 13, 2026

Form 8K Pulmatrix Inc For: 13 August By Investing.com - Investing.com Australia

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Morningstar

Aug 13, 2026

Pulmatrix Announces Second Quarter 2026 Financial Results And Progress On Merger - TradingView

Aug 13, 2026

Pulmatrix posts Q2 2026 net loss $1.04M, cash $2.2M; files Form S-4 for Eos merger - TradingView

Aug 13, 2026

Pulmatrix, Inc. Q2 2026: Net loss $1.05M, EPS $(0.29) — 10-Q Summary - TradingView

Aug 13, 2026

PULM: Q2 2026 featured lower expenses, a narrowed net loss, and progress toward the Eos merger - TradingView

Aug 13, 2026

Press Release: Pulmatrix Announces Second Quarter 2026 Financial Results and Progress on Merger - Moomoo

Aug 13, 2026

Aug 07, 2026